American Healthcare REIT is rated a hold, reaffirming my prior 2 hold ratings. This is contrarian to the bullish consensus of Wall Street and some analysts recently. AHR's strengths come from a growing portfolio and future pipeline, macro demand for senior care and outpatient medical, FFO growth, and modest leverage risk vs. peers. Consider this stock has a limited dividend growth history since 2024 and is trading at a 3x premium to book value, with some technical chart indicators also showing a hold pattern.
Some end-of-year Big Picture thoughts, including on the demographic destiny of falling population growth and the headwinds to economic growth that come with it. Why tariff-driven inflation is unlikely to generate anything more than a short-term bump followed by continued disinflation. Why the huge amount of cash on the sidelines could progressively become a tailwind to other types of financial assets, including dividend-paying stocks.
Here is how American Healthcare REIT (AHR) and KeyCorp (KEY) have performed compared to their sector so far this year.
The REIT sector returned to positive territory in November (+1.02%) after back-to-back months in the red. Mid caps (+3.53%) led the REIT sector in November followed by small caps (+3.38%) and large caps (+0.32%); micro caps (-8.76%) badly underperformed. 68.15% of REIT securities had a positive total return in November.
Does American Healthcare REIT (AHR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Demand tailwinds from the aging Baby Boomer cohort and record-low new construction underpin a multi-year runway for double-digit internal and external growth. Premiums to NAV enable accretive acquisitions, and current valuations underestimate the durability and longevity of the SH cycle for these REITs. VTR, WELL, and AHR are best positioned to benefit from exceptional internal growth combined with robust and accretive external growth.
Here is how American Healthcare REIT (AHR) and Axis Capital (AXS) have performed compared to their sector so far this year.
Here is how American Healthcare REIT (AHR) and Axis Capital (AXS) have performed compared to their sector so far this year.
Although the revenue and EPS for American Healthcare REIT (AHR) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
American Healthcare REIT (AHR) came out with quarterly funds from operations (FFO) of $0.44 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to FFO of $0.36 per share a year ago.
Here is how American Healthcare REIT (AHR) and Bankwell Financial Group, Inc. (BWFG) have performed compared to their sector so far this year.
American Healthcare REIT, Inc. (NYSE:AHR ) BofA Securities 2025 Global Real Estate Conference September 10, 2025 4:30 PM EDT Company Participants Danny Prosky - President, CEO & Director Brian Peay - Chief Financial Officer Conference Call Participants Farrell Granath - BofA Securities, Research Division Presentation Farrell Granath Research Analyst All right. Thank you, everyone, for joining for the American Healthcare REIT Roundtable.